EASTGATE BIOTECH CORP — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2016)

-$3.0M

Total Assets (FY2016)

$0

Total Equity (FY2016)

-$4.6M

Cash Flows from Operating Activities (FY2016)

-$389.5K

Source: EASTGATE BIOTECH CORP 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.